| Schedule Of Common Stock And Earnings Per Share |
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
|
|
September 29,
|
|
September 28,
|
|
|
|
|
2012
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings available to common shareholders
|
|
$ 17,490
|
|
$ 16,753
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
|
Common shares outstanding entire period
|
|
14,940
|
|
13,821
|
|
|
Weighted average common shares:
|
|
|
|
|
|
|
Issued during period
|
|
229
|
|
344
|
|
|
Canceled during period
|
|
(804)
|
|
(414)
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period
|
|
14,365
|
|
13,751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share from net earnings - basic
|
|
$ 1.22
|
|
$ 1.22
|
|
|
|
|
|
|
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period - basic
|
|
14,365
|
|
13,751
|
|
|
|
|
|
|
|
|
|
Dilutive effect of in-the-money equity awards
|
|
519
|
|
642
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period - diluted
|
|
14,884
|
|
14,393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share from net earnings - diluted
|
|
$ 1.18
|
|
$ 1.16
|
|
|
|
|
|
|
|
|
Equity awards for 522 and 15 shares of stock were not included in the computation of diluted EPS for the quarters ended September 29, 2012, and September 28, 2013, respectively, due to the fact that their effect would be anti-dilutive.
NOTE F — COMMON STOCK AND EARNINGS PER SHARE – CONTINUED
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
September 29,
|
|
September 28,
|
|
|
|
|
2012
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings available to common shareholders
|
|
$ 47,986
|
|
$ 58,742
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
|
Common shares outstanding entire period
|
|
14,940
|
|
13,821
|
|
|
Weighted average common shares:
|
|
|
|
|
|
|
Issued during period
|
|
107
|
|
154
|
|
|
Canceled during period
|
|
(374)
|
|
(339)
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period
|
|
14,673
|
|
13,636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share from net earnings - basic
|
|
$ 3.27
|
|
$ 4.31
|
|
|
|
|
|
|
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period - basic
|
|
14,673
|
|
13,636
|
|
|
|
|
|
|
|
|
|
Dilutive effect of in-the-money equity awards
|
|
391
|
|
496
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding during
|
|
|
|
|
|
|
period - diluted
|
|
15,064
|
|
14,132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share from net earnings - diluted
|
|
$ 3.19
|
|
$ 4.16
|
|
|
|
|
|
|
|
|
Equity awards for 1,357 and 445 shares of stock were not included in the computation of diluted EPS for the nine months ended September 29, 2012, and September 28, 2013, respectively, due to the fact that their effect would be anti-dilutive.
|